NEW YORK, Oct. 13, 2015 /PRNewswire/ -- This report
analyzes the worldwide markets for Remote Patient Monitoring
Systems in US$ Million. The report provides separate comprehensive
analytics for the US, Canada,
Japan, Europe, Asia-Pacific, Latin
America, and Rest of World. Annual estimates and forecasts
are provided for the period 2014 through 2020. Also, a seven-year
historic analysis is provided for these markets. Market data and
analytics are derived from primary and secondary research. Company
profiles are primarily based on public domain information including
company URLs. The report profiles 83 companies including many key
and niche players such as -
Abbott Laboratories
Aerotel Medical Systems
AMD Global Telemedicine, Inc.
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
Read the full report:
http://www.reportlinker.com/p03283192-summary/view-report.html
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers.............. I-2 Data Interpretation & Reporting
Level I-2 Quantitative Techniques & Analytics I-3 Product
Definitions and Scope of Study I-3
II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW.............. II-1 Remote Patient Monitoring
(RPM) - A Transformation Model for Health Care
Delivery..............II-1 Benefits for Patients, Physicians, &
Payer II-2 Improved Patient Outcomes and Promoting Self-Care II-2
Resource Optimization and Savings - A Key Benefit II-2 Payer
Benefits.............. II-3 Peek into Key Market Growth Drivers
II-3 Focus on Healthcare Economics Grows as Healthcare Expenditures
Rise Globally..............II-4 Table 1: Global Healthcare Spending
(in US$ Trillion): 2013-2018 (includes corresponding Graph/Chart)
II-5
Table 2: Healthcare Expenditure as a % of GDP Across Select
Countries (includes corresponding Graph/Chart) II-6
Table 3: Elderly Healthcare Expenditure as a % of GDP (includes
corresponding Graph/Chart) II-7 Aging Population Creates High
Demand II-7 Table 4: Ageing (65+) Demographics as % of Total
Population by Country (2000, 2011, 2020) (includes corresponding
Graph/Chart).............. II-8 Chronic Disease Management Presents
Huge Market Opportunity II-8 Table 5: World Market for Telehealth:
Patient Distribution (in %) by Disease Condition (includes
corresponding Graph/Chart).............. II-9
Table 6: Chronic Disease Management in Developed Countries (2014):
Percentage Distribution of Patient Population by Chronic Disease
Type in the US, Germany, and the
UK (includes corresponding Graph/Chart) II-10 Readmission Penalty
on Hospitals Provides Impetus to RPM II-10 Patient Non-Adherence to
Prescribed Medication Promotes RPM Market.............. II-11 Table
7: Medication Adherence Rates in the US by Condition (2012)
(includes corresponding Graph/Chart) II-11 Wearable Devices Help
Boost RPM Adoption II-12 Venture Capitalists Keen to Fund RPM
Technology Companies II-13 Table 8: Digital Health Venture Funding
in the US (2011-2014) (includes corresponding Graph/Chart)
II-14
Table 9: US Digital Health Venture Capital Funding by Category (in
%): 2014 (includes corresponding Graph/Chart) II-14 Market Issues
and Challenges..............II-15 High Cost of Remote Patient
Monitoring Systems II-15 Lack of Reimbursement..............II-15
Patient Privacy Concerns..............II-15 Small Practices
Challenged by Remote Monitoring Programs II-16 Security Issues of
Medical Devices II-16 Competitor Landscape..............II-17 Table
10: Leading Players in the Global Remote Patient Monitoring Market:
Percentage Breakdown of Market Share for Boston Scientific, GE
Healthcare, Medtronic, Philips Healthcare, St. Jude Medical, and
Others (includes corresponding Graph/Chart)..............II-17
2. MARKET TRENDS/ISSUES.............. II-18 Big Data Management
Crucial for Effective RPM II-18 Internet of Things (IoT) - Crucial
for Healthcare II-18 Cloud Computing: Enhancing RPM Adoption II-19
Partnerships Leverage on Mutual Expertise II-20 Will mHealth make
Conventional RPM Obsolete? II-21 Wireless Consumer Devices Favored
Over Telehealth II-22 Immobile Patients to Gain from Increased
Uptake of Remote Monitoring Devices.............. II-22 CVD
Continues to Grab Focus for Remote Monitoring II-23 Table 11:
Global Annual Medical Cost of CVD in US$ Billion (2010-2030)
(includes corresponding Graph/Chart) II-24
Table 12: Economic Burden of Cardiovascular Diseases between 2011
and 2015: Breakdown of Lost Output Value by Income Group (includes
corresponding Graph/Chart) II-24 Remote Monitoring - New Standard
of Care for Patients with CIEDs II-25 RPM to Reduce Costs
Associated with Diabetes Management II-26 Table 13: Global Diabetes
Mellitus Incidence among Ages 20-79 (2014E & 2035P): Prevalence
(in Millions) and Percentage Share by Geographic Region (includes
corresponding Graph/Chart).............. II-27
Table 14: Top Ten Countries Worldwide with the Highest Number of
People (in the Age Group 20-79 Years) with DM (in Millions): 2014E
& 2035P (includes corresponding Graph/Chart) II-28 Remote
Monitoring for Neurodegenerative Disease Conditions II-28 Remote
Monitoring of EEG & Treatment Adequacy II-29 Remote Monitoring
Crucial for COPD and Asthma Management II-30 Rising Significance of
Remote Blood Pressure Monitoring Benefits Market
Adoption..............II-31 Table 15: Death Rates Due to
Hypertension in Select Countries: 2012 (includes corresponding
Graph/Chart) II-32
Table 16: Percentage Prevalence Rate of High Blood Pressure for
Patients over 25 Years of Age by Region (1980 and 2013) -
Africa, America, South East Asia, Europe, Eastern Mediterranean, and Western
Pacific (includes corresponding Graph/Chart).............. II-33
Remote Patient Monitoring for Sleep Apnea II-33 Table 17:
Percentage Prevalence of Sleep Apnea in Co-Morbidities by Type of
Co-Morbidity (includes corresponding
Graph/Chart)..............II-34
3. PRODUCT OVERVIEW.............. II-35 Introduction..............
II-35 Remote Patient Monitoring vs. Telehealth II-35 Current
Monitoring Systems - A Systematic Review II-36 Remote Patient
Monitoring - Architecture II-36 Benefits & Challenges of Remote
Patient Monitoring Systems II-38
4. PRODUCT LAUNCHES/APPROVALS..............II-39 Omron Healthcare
Launches BP Monitor II-39 ALR Technologies Seeks FDA Approval for
New Health-e-Connect Feature.............. II-39 HTC Launches
Monitoring Device HTC Grip II-39 Covidien Receives CE Marking for
Nellcor System II-39 Intel-GE Launches Branded Health Harmony RPM
Service II-39 Dexcom Receives FDA Approval for Dexcom SHARE Device
II-39 Honeywell Unveils New Version of Genesis DM™ II-39 Honeywell
Unveils Latest Version of LifeStream™ II-40 AMD Introduces Live
Streaming Ultrasound Technology II-40 Vital Connect Receives FDA
Clearance for HealthPatch™ Biosensor II-40 OSTAR Healthcare
Launches Remote Patient Monitoring System in North America.............. II-40 Masimo's
Radius-7 Wearable Monitor Receives CE Approval II-40 CardioMEMS
System Receives FDA Approval II-40 ReliantHeart's Assist5®
Ventricular Assist Device Receives CE Certification..............
II-40 HealthInterlink Receives 510(k) clearance for Beacon version
2.0 II-41 Verizon Receives FDA Clearance for Patient Engagement
Tool II-41 Sensiotec Unveils Version 2.0 of Virtual Medical
Assistant® II-41 InfoBionic Receives CE Certification for MoMe™
System II-41 Baxter Receives CE Marking for VIVIA Hemodialysis
System II-41 Verizon Launches Remote Patient Monitoring Platform
II-41 Preventice Receives CE Certification for BodyGuardian®
Monitoring System..............II-41 Sorin's Smartview System
Receives FDA Approval II-42 Healthx Launches Remote Patient
Monitoring Platform II-42 Tactio Health Group Launches
TactioDiabetes II-42 FDA Approves RP-VITA By iRobot Corp. &
InTouch Health II-42
5. RECENT INDUSTRY ACTIVITY..............II-43 Integrity
Applications Enters Distribution Agreements with Chinese
Players.............. II-43 Roche and Qualcomm Enter Collaboration
II-43 Honeywell Life Care and MobileHelp Expand Collaboration II-43
Honeywell HomMed Changes Name to Honeywell Life Care II-43 Welch
Allyn Acquires HealthInterLink II-43 LabCorp and Envision
Healthcare Invest in Vivify Health II-43 Vital Connect Enters
Partnership with LifeWatch II-44 Aerocrine Collaborates with
Microsoft II-44 Preventice and eCardio Diagnostics Enter Strategic
Partnership II-44 Geneia Acquires Select Rights on ZephyrLIFE From
Covidien II-44 Healthsense Raises Funding for Remote Patient
Monitoring System II-44 Maxis Bhd and EWL Announce Partnership for
Health Monitoring M2M Solution.............. II-44 eCardio Signs
Agreement with Shandong Yocaly II-44 Medtronic Acquires
Cardiocom..............II-45 CardioNet Enters Agreement with IMEC
& Holst Centre II-45
6. FOCUS ON SELECT GLOBAL PLAYERS..............II-46 Abbott
Laboratories (US)..............II-46 Aerotel Medical Systems
(Israel) II-46 AMD Global
Telemedicine, Inc. (US) II-47 BIOTRONIK SE & Co. KG
(Germany)..............II-47
Boston Scientific Corporation (US) II-47 GE Healthcare Ltd.
(UK)..............II-48 Honeywell Life Care Solutions (US) II-48
Intelesens Ltd. (UK)..............II-49 LifeWatch AG (Switzerland)..............II-49 Masimo
Corporation (US)..............II-50 Medtronic Plc (Ireland)..............II-50 Mindray North
America (US)..............II-51 Nihon Kohden Corporation
(Japan) II-51 Omron Healthcare,
Inc. (US)..............II-51 Philips Healthcare (Netherlands) II-52 Qualcomm Life, Inc.
(US)..............II-52 St. Jude Medical Inc.
(US)..............II-53 Welch Allyn, Inc.
(US)..............II-53
7. GLOBAL MARKET PERSPECTIVE..............II-54 Table 18: World
Recent Past, Current & Future Analysis for Remote Patient
Monitoring Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin
America, and Rest of World Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2014 through
2020 (includes corresponding Graph/Chart)..............II-54
Table 19: World Historic Review for Remote Patient Monitoring
Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin
America, and Rest of World Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2007 through
2013 (includes corresponding Graph/Chart).............. II-55
Table 20: World 14-Year Perspective for Remote Patient Monitoring
Systems by Geographic Region - Percentage Breakdown of Value Sales
for US, Canada, Japan, Europe, Asia-Pacific, Latin
America, and Rest of World Markets for Years 2007, 2015
& 2020 (includes corresponding Graph/Chart) II-56
III. MARKET
1. THE UNITED STATES..............
III-1 A.Market Analysis.............. III-1 Key Drivers to Remote
Patient Monitoring Market III-1 Remote Monitoring Boosted by HRRP
III-1 High Life Expectancy Presents Strong Need for RPM III-2 Table
21: Population of the US (2010, 2030 & 2050): Percentage
Breakdown by Age Groups - Under 18, 18-64 years & 65+ years
(includes corresponding Graph/Chart) III-2 US - The Leading Market
for Remote Cardiac Monitoring III-2 Table 22: CVD in the US:
Cardiovascular Disease Prevalence in Adults by Gender & Age
Group (includes corresponding Graph/Chart).............. III-3
Table 23: CVD in the US: Cardiovascular Disease Incidence by Gender
& Age Group (per 1,000 Adults) (includes corresponding
Graph/Chart)..............III-3
Table 24: Leading Causes of CVD Fatalities in the US: Percentage
Breakdown of Mortality for Coronary Heart Disease, HBP, Heart
Failure, Stroke, and Others (includes corresponding
Graph/Chart)..............III-3 Chronic Disease Management - Focus
Area for Remote Monitoring III-4 Table 25: US Healthcare Spending
(2006-2020) (in US$ Trillion) (includes corresponding Graph/Chart)
III-5
Table 26: US Healthcare Market: Total Annual Expenditure in US$
Billion by Chronic Disorder/Disease (includes corresponding
Graph/Chart)..............III-5 Diabetes Statistics in the
US..............III-5 Table 27: Prevalence of Diabetes Mellitus in
the US (2013 & 2035): Number of People with DM (in Thousands)
in the 20-79 Age Group.............. III-6 Sleep Apnea in the
US..............III-6 Rise in COPD Incidence Drives RPM Adoption
III-7 Table 28: Chronic Obstructive Pulmonary Disorder (COPD)
Incidence in US (2014): COPD Prevalence in Millions by Age Group
(includes corresponding Graph/Chart) III-7 Reimbursement
Scenario..............III-7 Remote Monitoring Systems with FDA
510(k) Clearance (2014): III-8 Product Launches..............III-8
Strategic Corporate Developments III-11 Key Players..............
III-13 B.Market Analytics..............III-18 Table 29: US Recent
Past, Current & Future Analysis for Remote Patient Monitoring
Systems Analyzed with Annual Sales Figures in US$ Million for Years
2014 through 2020 (includes corresponding
Graph/Chart)..............III-18
Table 30: US Historic Review for Remote Patient Monitoring Systems
Analyzed with Annual Sales Figures in US$ Million for Years 2007
through 2013 (includes corresponding Graph/Chart)..............
III-18
2. CANADA.............. III-19
A.Market Analysis.............. III-19 Product Launch..............
III-19 B.Market Analytics..............III-20 Table 31: Canadian
Recent Past, Current & Future Analysis for Remote Patient
Monitoring Systems Analyzed with Annual Sales Figures in US$
Million for Years 2014 through 2020 (includes corresponding
Graph/Chart) III-20
Table 32: Canadian Historic Review for Remote Patient Monitoring
Systems Analyzed with Annual Sales Figures in US$ Million for Years
2007 through 2013 (includes corresponding
Graph/Chart).............. III-21
3. JAPAN.............. III-22
A.Market Analysis.............. III-22 Graying Population Spurs
Growth of Patient Monitoring Equipment III-22 Table 33: Japanese
Elderly (65+ Years) Population: 2000-2020 (includes corresponding
Graph/Chart) III-22 Key Player - Nihon Kohden Corporation III-22
B.Market Analytics..............III-23 Table 34: Japanese Recent
Past, Current & Future Analysis for Remote Patient Monitoring
Systems Analyzed with Annual Sales Figures in US$ Million for Years
2014 through 2020 (includes corresponding Graph/Chart) III-23
Table 35: Japanese Historic Review for Remote Patient Monitoring
Systems Analyzed with Annual Sales Figures in US$ Million for Years
2007 through 2013 (includes corresponding
Graph/Chart).............. III-24
4. EUROPE.............. III-25
A.Market Analysis.............. III-25 Prevalence of Diabetes in
Europe: Market Opportunity for CGM
Devices.............. III-25 B.Market Analytics..............III-26
Table 36: European Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by Geographic Region -
France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets
Independently Analyzed with Annual Sales Figures in US$ Million for
Years 2014 through 2020 (includes corresponding
Graph/Chart)..............III-26
Table 37: European Historic Review for Remote Patient Monitoring
Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets
Independently Analyzed with Annual Sales Figures in US$ Million for
Years 2007 through 2013 (includes corresponding
Graph/Chart).............. III-27
Table 38: European 14-Year Perspective for Remote Patient
Monitoring Systems by Geographic Region - Percentage Breakdown of
Value Sales for France,
Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years
2007, 2015 & 2020 (includes corresponding Graph/Chart)
III-28
4a. FRANCE.............. III-29
Market Analysis.............. III-29 Table 39: French Recent Past,
Current & Future Analysis for Remote Patient Monitoring Systems
Analyzed with Annual Sales Figures in US$ Million for Years 2014
through 2020 (includes corresponding
Graph/Chart)..............III-29
Table 40: French Historic Review for Remote Patient Monitoring
Systems Analyzed with Annual Sales Figures in US$ Million for Years
2007 through 2013 (includes corresponding
Graph/Chart).............. III-30
4b. GERMANY.............. III-31
A.Market Analysis.............. III-31 Key Player - Biotronik SE
& Co. KG III-31 B.Market Analytics..............III-32 Table
41: German Recent Past, Current & Future Analysis for Remote
Patient Monitoring Systems Analyzed with Annual Sales Figures in
US$ Million for Years 2014 through 2020 (includes corresponding
Graph/Chart)..............III-32
Table 42: German Historic Review for Remote Patient Monitoring
Systems Analyzed with Annual Sales Figures in US$ Million for Years
2007 through 2013 (includes corresponding
Graph/Chart).............. III-33
4c. ITALY.............. III-34
A.Market Analysis.............. III-34 Product Launch..............
III-34 B.Market Analytics..............III-34 Table 43: Italian
Recent Past, Current & Future Analysis for Remote Patient
Monitoring Systems Analyzed with Annual Sales Figures in US$
Million for Years 2014 through 2020 (includes corresponding
Graph/Chart)..............III-34
Table 44: Italian Historic Review for Remote Patient Monitoring
Systems Analyzed with Annual Sales Figures in US$ Million for Years
2007 through 2013 (includes corresponding
Graph/Chart).............. III-35
4d. THE UNITED KINGDOM..............III-36 A.Market
Analysis.............. III-36 Telecare and Elderly Population
Requirements - An Overview III-36 Self-Monitoring Blood Glucose
Meters Gain Popularity III-37 Product Approval..............III-37
Key Players.............. III-37 B.Market
Analytics..............III-39 Table 45: UK Recent Past, Current
& Future Analysis for Remote Patient Monitoring Systems
Analyzed with Annual Sales Figures in US$ Million for Years 2014
through 2020 (includes corresponding
Graph/Chart)..............III-39
Table 46: UK Historic Review for Remote Patient Monitoring Systems
Analyzed with Annual Sales Figures in US$ Million for Years 2007
through 2013 (includes corresponding Graph/Chart)..............
III-40
4e. SPAIN.............. III-41
Market Analysis.............. III-41 Table 47: Spanish Recent Past,
Current & Future Analysis for Remote Patient Monitoring Systems
Analyzed with Annual Sales Figures in US$ Million for Years 2014
through 2020 (includes corresponding
Graph/Chart)..............III-41
Table 48: Spanish Historic Review for Remote Patient Monitoring
Systems Analyzed with Annual Sales Figures in US$ Million for Years
2007 through 2013 (includes corresponding
Graph/Chart).............. III-42
4f. RUSSIA.............. III-43
Market Analysis.............. III-43 Table 49: Russian Recent Past,
Current & Future Analysis for Remote Patient Monitoring Systems
Analyzed with Annual Sales Figures in US$ Million for Years 2014
through 2020 (includes corresponding
Graph/Chart)..............III-43
Table 50: Russian Historic Review for Remote Patient Monitoring
Systems Analyzed with Annual Sales Figures in US$ Million for Years
2007 through 2013 (includes corresponding
Graph/Chart).............. III-44
4g. REST OF EUROPE..............
III-45 A.Market Analysis.............. III-45 Strategic Corporate
Developments III-45 Key Players.............. III-45 B.Market
Analytics..............III-47 Table 51: Rest of European Recent
Past, Current & Future Analysis for Remote Patient Monitoring
Systems Analyzed with Annual Sales Figures in US$ Million for Years
2014 through 2020 (includes corresponding Graph/Chart) III-47
Table 52: Rest of European Historic Review for Remote Patient
Monitoring Systems Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2013 (includes corresponding
Graph/Chart)..............III-48
5. ASIA-PACIFIC..............
III-49 A.Market Analysis.............. III-49 Outlook..............
III-49 Improving Infrastructure Facilitates RPM Adoption III-49
Undiagnosed Diabetic Population Offers Potential for Remote
Monitoring.............. III-49 B.Market
Analytics..............III-50 Table 53: Asia-Pacific Recent Past,
Current & Future Analysis for Remote Patient Monitoring Systems
by Region - China and Rest of
Asia-Pacific Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2014 through 2020 (includes
corresponding Graph/Chart) III-50
Table 54: Asia-Pacific Historic Review for Remote Patient
Monitoring Systems by Region - China and Rest of Asia-Pacific Markets
Independently Analyzed with Annual Sales Figures in US$ Million for
Years 2007 through 2013 (includes corresponding Graph/Chart)
III-51
Table 55: Asia-Pacific 14-Year
Perspective for Remote Patient Monitoring Systems by Region -
Percentage Breakdown of Value Sales for China and Rest of Asia-Pacific Markets for
Years 2007, 2015 & 2020 (includes corresponding
Graph/Chart).............. III-52
5a. CHINA.............. III-53
A.Market Analysis.............. III-53 Large Population Results in
Quicker RPM Adoption III-53 Table 56: Healthcare Expenditure in
China as a % of GDP (2006-2015)
(includes corresponding Graph/Chart) III-54
Table 57: Percentage of Population Aged 65 and Above in
China (2000-2020) (includes
corresponding Graph/Chart) III-54
Table 58: Incidence of Chronic Diseases in China (2014) (includes corresponding
Graph/Chart) III-54 China: An
Untapped Goldmine for Blood Glucose Monitoring
Devices.............. III-55 Strategic Corporate Development III-55
B.Market Analytics..............III-56 Table 59: Chinese Recent
Past, Current & Future Analysis for Remote Patient Monitoring
Systems Analyzed with Annual Sales Figures in US$ Million for Years
2014 through 2020 (includes corresponding
Graph/Chart)..............III-56
Table 60: Chinese Historic Review for Remote Patient Monitoring
Systems Analyzed with Annual Sales Figures in US$ Million for Years
2007 through 2013 (includes corresponding
Graph/Chart).............. III-56
5b. REST OF ASIA-PACIFIC..............III-57 A.Market
Analysis.............. III-57 India: Remote Patient Monitoring Gains
Popularity III-57 Rising Diabetic Populace Spurs Growth in Remote
Glucose Monitoring Devices..............III-57 Strategic Corporate
Development III-58 B.Market Analytics..............III-59 Table 61:
Rest of Asia-Pacific Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems Analyzed with Annual Sales
Figures in US$ Million for Years 2014 through 2020 (includes
corresponding Graph/Chart) III-59
Table 62: Rest of Asia-Pacific Historic Review for Remote Patient
Monitoring Systems Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2013 (includes corresponding
Graph/Chart)..............III-60
6. LATIN AMERICA..............
III-61 Market Analysis.............. III-61 Table 63: Latin
American Recent Past, Current & Future Analysis for Remote
Patient Monitoring Systems by Region - Brazil and Rest of Latin American Markets
Independently Analyzed with Annual Sales Figures in US$ Million for
Years 2014 through 2020 (includes corresponding Graph/Chart)
III-61
Table 64: Latin American Historic Review for Remote Patient
Monitoring Systems by Region - Brazil and Rest of Latin American Markets
Independently Analyzed with Annual Sales Figures in US$ Million for
Years 2007 through 2013 (includes corresponding
Graph/Chart)..............III-62
Table 65: Latin American 14-Year Perspective for Remote Patient
Monitoring Systems by Region - Percentage Breakdown of Value Sales
for Brazil and Rest of Latin
American Markets for Years 2007, 2015 & 2020 (includes
corresponding Graph/Chart).............. III-63
6a. BRAZIL.............. III-64
Market Analysis.............. III-64 Table 66: Brazilian Recent
Past, Current & Future Analysis for Remote Patient Monitoring
Systems Analyzed with Annual Sales Figures in US$ Million for Years
2014 through 2020 (includes corresponding Graph/Chart) III-64
Table 67: Brazilian Historic Review for Remote Patient Monitoring
Systems Analyzed with Annual Sales Figures in US$ Million for Years
2007 through 2013 (includes corresponding
Graph/Chart).............. III-65
6b. REST OF LATIN AMERICA..............III-66 Market
Analysis.............. III-66 Table 68: Rest of Latin American
Recent Past, Current & Future Analysis for Remote Patient
Monitoring Systems Analyzed with Annual Sales Figures in US$
Million for Years 2014 through 2020 (includes corresponding
Graph/Chart) III-66
Table 69: Rest of Latin American Historic Review for Remote Patient
Monitoring Systems Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2013 (includes corresponding
Graph/Chart)..............III-67
7. REST OF WORLD.............. III-68 A.Market
Analysis.............. III-68 Key Player - Aerotel Medical Systems
(Israel) III-68 B.Market
Analytics..............III-69 Table 70: Rest of World Recent Past,
Current & Future Analysis for Remote Patient Monitoring Systems
Analyzed with Annual Sales Figures in US$ Million for Years 2014
through 2020 (includes corresponding Graph/Chart) III-69
Table 71: Rest of World Historic Review for Remote Patient
Monitoring Systems Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2013 (includes corresponding
Graph/Chart).............. III-70
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 83 (including Divisions/Subsidiaries -
85)
The United States (55)
Canada (6) Japan (1) Europe (16) - Germany (3) - The United Kingdom (4) - Italy (1) - Rest of Europe (8) Asia-Pacific (Excluding Japan) (4)
Middle East (3)
Read the full report:
http://www.reportlinker.com/p03283192-summary/view-report.html
About Reportlinker
ReportLinker is an award-winning market research solution.
Reportlinker reviews, finds and organizes the latest industry data
so you get all the market research you need - instantly, in one
place.
http://www.reportlinker.com
__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/global-remote-patient-monitoring-system-industry---reportlinker-review-300159088.html
SOURCE Reportlinker